The FDA Backdoor to MDMA Rescheduling
FDA rescheduling may provide a compelling model for efforts to decriminalize and destigmatize other substances moving forward.
DEA
-
Read more: The FDA Backdoor to MDMA Rescheduling -
Read more: Thank Ketamine for the Telehealth Extension Thank Ketamine for the Telehealth Extension
The telemedicine extension is not just for psychedelics; easing these restrictions means relaxing them for other controlled substances as well.
-
Read more: Psychedelic Policy on the Federal Level: Key Takeaways from a Petrie-Flom Center Panel Psychedelic Policy on the Federal Level: Key Takeaways from a Petrie-Flom Center Panel
Key takeaways from a virtual panel discussion with three leading psychedelic policy advocates.
-
Read more: The Biden Administration Should Resolve Cannabis Regulation Chaos The Biden Administration Should Resolve Cannabis Regulation Chaos
The Biden Administration has the opportunity to be the first administration to rid our legal system of cannabis regulation chaos.
-
Read more: A Sensible, Evidence-Based Proposal for Kratom Reform A Sensible, Evidence-Based Proposal for Kratom Reform
Instead of fueling the long-failed War on Drugs by repressing kratom, the FDA should strengthen consumer confidence by creating uniform regulations.
-
Read more: How Supervised Injection Sites Can Help Address the Overdose Crisis How Supervised Injection Sites Can Help Address the Overdose Crisis
To save lives and improve individual and community outcomes, supervised injection sites should be part of the response to the opioid epidemic.
-
Read more: Advancing a Public Health-Promoting National Opioid Policy Advancing a Public Health-Promoting National Opioid Policy
An American public health and safety-promoting drug policy agenda grounded in sound science is long overdue.
-
Read more: Bold Steps Needed to Correct Course in US Drug Policies Bold Steps Needed to Correct Course in US Drug Policies
Moving the United States beyond the opioid overdose crisis and pernicious inequities in law enforcement requires bold, innovative solutions.
-
Read more: The Prescription Drug Abuse and Overdose Crisis: Focus on the Supply Chain The Prescription Drug Abuse and Overdose Crisis: Focus on the Supply Chain
By Scott Burris There’s so much we still don’t know about the prescription opioid problem. The partial remedies advanced so far reflect this: Prescription Drug Monitoring Programs, which in essence define the problem as doctor-shopping patients; treatment guidelines, which define the problem as doctors without expertise; and crackdowns on “pill-mills,” which see the issue as…